Glyburide is frequently used to treat gestational diabetes due to its low fetal accumulation resulting from placental efflux by the breast cancer resistance protein (BCRP/ABCG2) transporter. However, there is little understanding of the potential consequences of reduced placental BCRP function in pregnant women prescribed glyburide. Babies born to this population of women may be at an elevated risk of neonatal hypoglycemia potentially leading to low birth weight, increased morbidity, and impaired neurological development. The purpose of this dissertation research was to determine the influence of genetic and dietary factors on the placental expression of BCRP and its ability to transport glyburide. In 10 human term placentas, there were no differences in expression of BCRP mRNA or protein across the disc, supporting the use of a single sampling site to examine the interindividual expression of this transporter. In term placentas from 108 donors, ethnicity, transcription factor expression, and single nucleotide polymorphisms (SNPs) were associated with BCRP expression including the frequent C421A SNP, which correlated with lower BCRP protein expression. Further in vitro studies revealed that C421A-BCRP overexpressing cells had low BCRP protein expression at the cell surface and impaired transport of the BCRP substrate glyburide. Additionally, the dietary soy isoflavone genistein competitively inhibited the BCRP-mediated transport of glyburide in overexpressing cells (wild-type, WT-BCRP and C421A-BCRP) and human choriocarcinoma placental BeWo cells that endogenously express BCRP. Importantly, genistein inhibited glyburide transport in placental BeWo cells at concentrations that are physiologically relevant (IC50=0.18 ± 0.11 μM). Finally, estrogen receptor-mediated signaling stimulated by prolonged genistein treatment (48 h) down-regulated BCRP mRNA and protein expression in BeWo cells leading to reduced efflux of glyburide out of cells. Conversely, genistein (48 h) did not alter BCRP protein expression in term placental explants, suggesting that the regulation of placental BCRP expression by genistein may be limited to choriocarcinoma BeWo cells. Together, this research provides population and mechanistic data that demonstrate how a genetic variant (C421A) and diet (genistein) may alter the maternal-fetal disposition of glyburide as well as other chemicals that are BCRP substrates.
Subject (authority = RUETD)
Topic
Toxicology
Subject (authority = ETD-LCSH)
Topic
Breast--Cancer
Subject (authority = ETD-LCSH)
Topic
Glibenclamide--Therapeutic use
RelatedItem (type = host)
TitleInfo
Title
Rutgers University Electronic Theses and Dissertations
Identifier (type = RULIB)
ETD
Identifier
ETD_6896
PhysicalDescription
Form (authority = gmd)
electronic resource
InternetMediaType
application/pdf
InternetMediaType
text/xml
Extent
1 online resource (xx, 323 p. : ill.)
Note (type = degree)
Ph.D.
Note (type = bibliography)
Includes bibliographical references
Note (type = statement of responsibility)
by Kristin Marie Bircsak
RelatedItem (type = host)
TitleInfo
Title
Graduate School - New Brunswick Electronic Theses and Dissertations
Identifier (type = local)
rucore19991600001
Location
PhysicalLocation (authority = marcorg); (displayLabel = Rutgers, The State University of New Jersey)
Rutgers University. Graduate School - New Brunswick
AssociatedObject
Type
License
Name
Author Agreement License
Detail
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.